TrialReader


Optical Coherence Tomography of Airway and Pleural Disorders

NCT00580892 — Withdrawn, University of California, Irvine

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT00580892
StatusWithdrawn - Not a clinical trial study
Study typeObservational
SponsorUniversity of California, Irvine (Other); collaborators: Beckman Laser Institute University of California Irvine
ConditionsDisorder of Pleura and Pleural Cavity
InterventionsOptical Coherence Tomography imaging (Device)
Datesstart 2007-07-01, primary completion 2018-07-01 (estimated), completion 2018-07-01 (estimated), first posted 2007-12-27, last updated 2022-10-20
Locations1 site in United States

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Disorder of Pleura and Pleural Cavity All trials of Optical Coherence Tomography imaging

-Summary

The researcher can use Optical coherence tomography a near-infrared diode to emit light that can produce images of the specimen under investigation and provide information about tissue abnormalities without causing damage.

Expand all sections  ·  Collapse all

+Detailed description

The researcher can use Optical coherence tomography endoscopic imaging to improve diagnosis and treatment of airway and pleural malignancy. In the events of burn injury and smoke inhalation injury, the Optical coherence tomography can determine the change of the airway tissues and severity of airway injury.

During endoscopic procedure the lesions will be biopsied and prepared by standard histologic methods. The Optical coherence tomography endoscopic imaging can measured histologic of the tissue samples and compared to standard histologic examination. The Optical coherence tomography endoscopic imaging can measured the epithelial thickness and compared to visual inspection of the mucosa on bronchoscopy.

+Arms and interventions

ArmTypeInterventionsDescription
Airway and Pleural DisordersDevice: Optical Coherence Tomography imagingOptical Coherence Tomography imaging
  • Optical Coherence Tomography imaging (Device): Optical Coherence Tomography imaging

+Outcome measures

Primary outcomes

  • histopathology [up to 4 weeks]

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* Adult 18 or older, male or female.
* Plans for bronchoscopic with possible biopsy procedures.

Exclusion Criteria:

* Age less than 18 years of age
* Not plan for bronchoscopic with possible biopsy procedures.
* Pregnant or breastfeeding.

+Locations (1)

FacilityCityCountryStatus
Pulmonary and Critical Care MedicineIrvine, CaliforniaUnited States

+Investigators

My Notes